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Endotoxin-Neutralizing Antimicrobial Proteins of the Human
Placenta1
Hun Sik Kim,* Ju Hyun Cho,* Hyoung Woo Park,† Ho Yoon,‡ Mi Sun Kim,§ and
Sun Chang Kim2*
Microbial colonization and infection of placental tissues often lead to adverse pregnancy outcomes such as preterm birth, a leading
cause of neonatal morbidity and mortality. The fetal membranes of the placenta, a physical and active barrier to microbial
invasion, encapsulate the fetus and secure its intrauterine environment. To examine the innate defense system of the human
placenta, antimicrobial peptides were isolated from the fetal membranes of human placenta and characterized biochemically. Two
salt-resistant antimicrobial host proteins were purified to homogeneity using heparin-affinity and reversed-phase HPLC. Char-
acterization of these proteins revealed that they are identical to histones H2A and H2B. Histones H2A and H2B showed dose-
dependent inhibition of the endotoxin activity of LPS and inhibited this activity by binding to and therefore blocking both the core
and lipid A moieties of LPS. Consistent with a role for histones in the establishment of placental innate defense, histones H2A and
H2B were highly expressed in the cytoplasm of syncytiotrophoblasts and amnion cells, where the histone proteins were localized
mainly to the epithelial surface. Furthermore, culturing of amnion-derived WISH cells led to the constitutive release of histone
H2B, and histones H2A and H2B contribute to bactericidal activity of amniotic fluid. Our studies suggest that histones H2A and
H2B may endow the epithelium of the placenta with an antimicrobial and endotoxin-neutralizing barrier against microorganisms
that invade this immune-privileged site. The Journal of Immunology, 2002, 168: 2356–2364.
P regnancy is an immunological balancing act in which themother’s immune system has to remain tolerant of alloge-neic fetal tissues and yet maintain normal immune com-
petence for defense against invading microorganisms (1, 2). Many
studies indicate that suppression of maternal immunity provides an
immune-privileged microenvironment for the fetus. Cytokines (3),
the nonclassical MHC molecule HLA-G (4), Fas (5), TNF-related
ligands (6), suppression of the complement system (7), and pos-
sibly catabolizing enzymes for T cell growth-promoting nutrients
(8) expressed at the decidual-placental interface all have been im-
plicated in the modulation of maternal immune competence. How-
ever, this host immune suppression for allograft survival (9) does
leave the placenta and fetus more susceptible to microbial
infection.
Preterm birth remains the major cause of neonatal morbidity and
mortality. Although the etiology of preterm labor and delivery is
unknown, there is overwhelming epidemiological, pathological,
and immunological evidence to implicate the infection of the
uteroplacental unit as a causative factor in a substantial number of
preterm births (10–12). Infection-related prematurity is most
likely caused by an infection that ascends from the lower genital
tract to the upper tract, with the end stage being a positive amniotic
fluid culture (13, 14). Fetal exposure to high concentrations of
microorganisms leads to colonization of the fetus lung airways and
subsequent pneumonia, sepsis, and meningitis (15, 16). Even a
trivial fetal infection can trigger an exaggerated inflammatory re-
sponse, inducing cytokine cascades and resulting in the eventual
demise of the neonate (17). Despite the large number of infectious
insults during pregnancy, the outcome is most often a normal new-
born. This is undoubtedly due to the presence of highly effective
fetal defense mechanisms that serve to limit the bacterial infection
of placental tissues. The placenta is a highly selective mechanical
and immunological barrier against the dissemination of infectious
agents by hematogenous routes or by the ascending route from the
vagina (18). These defenses serve to limit both the degree and
frequency of bacterial colonization within the placenta. Therefore,
the placenta may contain effective protection mechanisms that,
upon their failure, permit the establishment of a bacterial infection
in fetal tissues.
During the last several decades, it became clear that antimicro-
bial proteins serve a key protective role in the host defense of
widely divergent animal species. Such proteins are active compo-
nents of the innate defense system, acting as effector molecules
with the capacity to kill a broad spectrum of microorganisms (19–
21). In contrast to highly specific adaptive immunity, which is not
triggered rapidly enough to protect against exposure to pathogens,
the innate immune system provides a rapid and nonspecific re-
sponse, and thereby contributes to the first line of defense against
infection. The recent discovery of antimicrobial proteins within the
human respiratory epithelium (22, 23), the gastrointestinal epithe-
lium (24, 25), Paneth cells of the small intestine (26, 27), and the
urogenital epithelium (28) has prompted us to examine placental
tissue and associated membranes for similar agents. From the fetal
membrane of human placenta, we have isolated two salt-resistant
proteins with antimicrobial and endotoxin-neutralizing activities.
These proteins were characterized and shown to be histones H2A
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and H2B. H2A and H2B were expressed in the cytoplasm of syn-
cytiotrophoblasts and amnion cells, where they were associated
mainly with the surface epithelium. In addition, amnion epithelial
cells were shown to release histone H2B constitutively. Our find-
ings suggest that histones H2A and H2B may provide protection
against penetration by microorganisms into the immune-privileged
human placental tissues.
Materials and Methods
Materials
Polymixin B (PMB),3 PMB nonapeptide (PMBN), Escherichia coli
0111:B4 LPS, E. coli EH100 (Ra mutant) LPS, E. coli J5 (Rc mutant) LPS,
E. coli F583 (Rd2 mutant) LPS, and E. coli lipid A were purchased from
Sigma-Aldrich (St. Louis, MO). DMEM, FBS, penicillin, and streptomycin
were obtained from Life Technologies (Gaithersburg, MD). Calf thymus
histones H2A and H2B were from Roche (Mannheim, Germany). Anti-
histone H2A (BWA3) and anti-histone H2B (LG2-2) mAbs were kindly
provided by Dr. M. Monestier (Temple University School of Medicine,
Philadelphia, PA).
Tissues
Samples of human second trimester (n  5) and term placentas (n  3)
were obtained from elective pregnancy terminations and normal cesarean
section deliveries, respectively, in accordance with a protocol approved by
the Human Subjects Committee of the University of Yonsei Medical Cen-
ter (Seoul, Korea). The tissues were manually dissected and processed
immediately.
Amniotic fluid collection
Informed consents were obtained from all patients from whom amniotic
fluid samples were collected. Amniotic fluid samples at term pregnancy
were obtained from 20 patients who were not in labor and were undergoing
amniocentesis for fetal lung maturity before scheduled elective repeated
cesarean deliveries. All amniotic fluid samples selected for analysis were
free of contamination from blood components. Amniotic fluid samples
were centrifuged, and the supernatant was stored at 80°C until analyzed.
Purification of antimicrobial proteins
Antimicrobial proteins were purified from term human placenta by a pre-
viously described method (29) with slight modifications. The placenta (tis-
sue weight, 100 g) was homogenized using a Waring blender (Waring,
New Hartford, CT) in 500 ml of acidic medium containing 1% (v/v) tri-
fluoroacetic acid (TFA), 1 M of HCl, 5% (v/v) formic acid, 1% (w/v) NaCl,
and pepstatin A at 10 g/ml. The homogenate was centrifuged at 20,000
g for 30 min in a Himac SCR20BR (Hitachi, Tokyo, Japan), and the su-
pernatant was collected. The material in the supernatant was then subjected
to reversed-phase concentration using a Sep-Pak C18 cartridge (Millipore,
Milford, MA), which was activated with 80% acetonitrile containing 0.1%
TFA and flushed with 0.1% TFA to remove the excess acetonitrile. After
being loaded with the supernatant, the cartridge was washed with 20 ml of
0.1% TFA, and the material trapped in the Sep-Pak C18 cartridge was
eluted with 6 ml of 80% acetonitrile containing 0.1% TFA. The eluate was
then lyophilized and subsequently resuspended in 10 ml of 0.01 M of
Tris-HCl (pH 7.5) containing 0.01 M of NaCl. The resuspended eluate was
loaded onto a 1  10-cm heparin-Sepharose column (Amersham Bio-
sciences, Uppsala, Sweden) equilibrated with 0.01 M of Tris-HCl (pH 7.5)
containing 0.01 M of NaCl. The bound material was eluted by a stepwise
gradient of 0.5, 1, and 3 M of NaCl, and concentrated using a Sep-Pak C18
cartridge. Each eluted sample (5 l) was then assayed for antimicrobial
activity against E. coli. The active eluate was subjected to chromatography
on a C4 reversed-phase HPLC column (5 m, 4.6  250 mm, Vydac;
Millipore). The proteins loaded onto the C4 column were eluted with a
0–100% gradient of buffer A (0.13% heptafluorobutyric acid (HFBA) in
water) and buffer B (0.13% HFBA in acetonitrile) at a flow rate of 1 ml/min
over 2 h. Each fraction was dried under vacuum and resuspended in water.
A sample of the resuspended proteins (5 l) was assayed for antimicrobial
activity. Final purification of two active fractions was achieved by re-
versed-phase HPLC on a C4 column with a slower gradient using 0.1%
TFA as an ion-pairing agent. The purity of the isolated proteins was as-
sessed by reversed-phase HPLC and tricine SDS-PAGE. Protein concen-
tration was determined using a bicinchoninic acid protein assay (Pierce,
Rockford, IL) with BSA as a standard.
Structural analyses
The m.w. of the antimicrobial proteins was determined by matrix-associ-
ated laser desorption ionization mass spectroscopy (MALDI-MS; Kratos
Kompact MALDI, Manchester, U.K.). Lyophilized protein (1 nmol) was
dissolved in 50% acetonitrile containing 7% (w/v) sinapinic acid and
mixed with a platinum probe. After removing the solvent in warm air, the
protein that had been adsorbed to the platinum probe was applied to a
vacuum chamber and analyzed. Proteins were hydrolyzed by incubation in
evacuated tubes with 6 M of HCl containing 0.1% phenol at 110°C for
24 h. Total composition of the proteins was determined using a Pico-tag
analysis system on a Beckman 121 MB amino acid analyzer (Fullerton,
CA). The N-terminal sequence analysis of the proteins was performed by
automatic Edman degradation on a gas-phase sequencer (Applied Biosys-
tems, Foster City, CA).
Antimicrobial activity assay
The minimal inhibitory concentration (MIC) of the antimicrobial proteins
was determined with a modified broth dilution assay (30). The test strain E.
coli ML35 was inoculated into culture medium (3% trypticase soy broth)
and cultured overnight at 37°C. An aliquot of this culture (50 l) was
transferred to 50 ml of fresh medium and incubated for an additional 3 h
at 37°C so that the cells used in the assay are in mid-logarithmic phase.
Bacteria were harvested by centrifugation, washed with 10 mM of sodium
phosphate buffer (pH 7.4), and resuspended in the same buffer. A 2-fold
dilution series of the purified proteins in 10 mM of sodium phosphate
buffer was prepared, and serial dilutions (50 l) were added to 50 l of 5
104 CFU in each well of a static 96-well polypropylene microtiter plate
(Costar, Corning, NY). Where indicated, fixed concentrations of NaCl
were added to each well of the microtiter plate (Table I). After incubation
for 3 h at 37°C, fresh medium was added to the mixture and incubated at
37°C for 16 h. The inhibition of growth was determined by measuring the
absorbance at 620 nm with a model 550 microplate reader (Bio-Rad, Rich-
mond, CA). The lowest concentration of peptide that completely inhibited
bacterial growth was defined as the MIC. The MICs were obtained in
triplicates on three independent measurements.
Measurement of LPS binding and neutralization
Assay for binding to immobilized LPS. The wells of a microtiter plate
(PolySorp; Nunc, Roskilde, Denmark) were coated with LPS by incubating
100 l/well of 30 g/ml E. coli 0111:B4 LPS in 0.2 M of sodium carbon-
ate-bicarbonate buffer (pH 9.4) for 1 h at 37°C. The LPS solution was
removed, and the plates were blocked by incubation for 1 h at room tem-
perature with TBS (pH 7.2) containing 3% (w/v) BSA. The blocked wells
were then washed three times with 0.05% Tween 20 in TBS (TTBS).
Histone H2B in TTBS (1 g/ml) was added to each well in a total volume
of 100 l/well. To study the specificity of binding of histone H2B to LPS,
various types of LPS (final concentration of 0.5–50 g/ml) were added to
each well of the microtiter plate immediately after the addition of histone
H2B. Binding of histone H2B was allowed for 1 h at room temperature,
and the microtiter plate was washed three times with TTBS. Anti-histone
H2B mAb (1 g/ml), 100 l/well, in TTBS, was added to the plate, which
was then incubated for 1 h at room temperature. The plate was then washed
with TTBS as above and incubated for 1 h at room temperature with 100
l/well peroxidase-conjugated goat anti-mouse IgG (1/5000 dilution) in
3 Abbreviations used in this paper: PMB, polymyxin B; DAPI, 4,6-diamidino-2-
phenylindole; HFBA, heptafluorobutyric acid; LAL, Limulus amebocyte lysate;
MALDI-MS, matrix-associated laser desorption ionization mass spectroscopy; MIC,
minimal inhibitory concentration; PMBN, PMB nonapeptide; TFA, trifluoroacetic
acid.
Table I. Effect of NaCl on MICs of antimicrobial proteins against
E. coli
Additive
Concb
(mM)
MIC (g/ml)a
Histone H2A Histone H2B Magainin II
None 10 10 20
NaCl 100 10 10 20
150 10 10 50
200 15 15 100
300 20 20 200
a These are the average values of three experiments.
b Conc, concentration.
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TTBS. Immunoreactivity was visualized by adding 200 l of 3,3,5,5-
tetramethylbenzidine (Sigma-Aldrich) substrate solution. The reaction was
stopped after 30 min by adding 100 l of 0.18 M of sulfuric acid, and the
absorbance at 450 nm was determined using a model 550 microplate reader
(Bio-Rad).
Limulus amebocyte lysate (LAL) assay. The in vitro neutralization of
LPS activity by histone proteins was assessed by the LAL chromogenic
assay (QCL-1000; BioWhittaker, Walkersville, MD), according to the
manufacturer’s protocol.
TNF- production by RAW264.7 cells. The murine macrophage cell line
RAW264.7 was obtained from the American Type Culture Collection (Ma-
nassas, VA) and grown in DMEM supplemented with 10% heat-inactivated
FBS. The cells were plated at 106 cells/ml/well in a 24-well plate (Nunc),
incubated overnight, then stimulated with LPS (E. coli 0111:B4) at a final
concentration of 10 ng/ml for 6 h. Immediately after LPS addition, histone
proteins were added to a final concentration of 0.5–20 g/ml. The culture
supernatants were assayed for TNF- using an ELISA (Roche). The via-
bility of RAW264.7 cells was assessed by the viable cell proliferation assay
(CellTiter 96 Aqueous One solution; Promega, Madison, WI), according to
the manufacturer’s protocol.
Immunohistochemistry
Fresh human placenta was placed in 10% formaldehyde dissolved in PBS,
incubated overnight at 4°C, and embedded in paraffin. Serial cross sections
(4 m) were deparaffinized, treated with 0.3% hydrogen peroxide in meth-
anol for 30 min, and washed extensively, first with water and then with
PBS. Immunostaining was performed using a biotin-avidin-peroxidase
method (Vectastain Elite ABC kit; Vector Laboratories, Burlingame, CA).
Briefly, the sections were incubated with 1% normal blocking serum for 20
min at room temperature and then incubated for 1 h with either anti-histone
H2A (50 g/ml) mAb or anti-histone H2B (10 g/ml) mAb. Sections were
developed with chromogen diaminobenzidine for 10 min and then coun-
terstained with Mayer’s hematoxylin and mounted. Control incubations
were performed using mouse isotype-matched IgG as a primary Ab.
Immunocytochemistry
Fresh WISH cells were seeded into Lab-Tek tissue-culture chamber slides
(Nunc) and grown for 24 h. Cells were washed with PBS, fixed in 4%
paraformaldehyde in PBS for 10 min, and permeabilized with 0.2% Triton
X-100 or not permeabilized for immunolabeling of histones H2A and H2B
at the surface of amnion WISH cells. After further washing, immunostain-
ing was performed using a biotin-streptavidin-FluorGreen method (Inno-
Genex IHC Immunofluorescence kit; InnoGenex, San Ramon, CA). The
cells were then blocked with a blocking reagent for 5 min at room tem-
perature and incubated for 1 h with either anti-histone H2A (50 g/ml)
mAb or anti-histone H2B (10 g/ml) mAb, biotinylated secondary Ab, and
streptavidin-FluorGreen conjugate in sequence. The cells were rinsed,
counterstained with 4,6-diamidino-2-phenylindole (DAPI), mounted, and
viewed with confocal laser-scanning microscopy (LSM410; Zeiss,
Oberkochen, Germany).
Amnion cell culture
The human amnion-derived cell line WISH was obtained from the Korean
Cell Line Bank (Seoul, Korea) and grown in DMEM supplemented with
10% FBS, 100 U/ml penicillin G, and 0.1 mg/ml streptomycin. Cells were
incubated at 37°C in a humidified atmosphere of 5% CO2 and 95% air. Cell
cultures were transferred with 1 mM EDTA/0.05% trypsin (Life Technol-
ogies) upon reaching confluence and plated out at 1  105 cells/ml/well in
a 24-well culture plate in the same media. To study the production of
histone H2B in culture in response to LPS treatment, media samples were
withdrawn and replaced with fresh media 24 h after plating. E. coli
0111:B4 LPS was added to the fresh media, and the cells were incubated
for various indicated times. The conditioned media were then removed and
centrifuged at 500  g for 10 min. The supernatants were recovered and
stored at 20°C for immunoassay.
Measurement of histone H2B
The levels of histone H2B in the cultured WISH cell supernatant and am-
niotic fluid samples were determined with a sandwich ELISA. Microtiter
plates (MaxiSorp; Nunc) were coated with 100 l/well of 30 g/ml DNA
in 0.2 M of sodium carbonate-bicarbonate buffer (pH 9.4) by incubation for
1 h at 37°C. Plates were blocked for 1 h at room temperature with TBS (pH
7.2) containing 3% (w/v) BSA, and then washed three times with TTBS.
Culture supernatants (100 l) or serial dilutions of amniotic fluid samples
(100 l) were added to each well, and the reaction mixture was incubated
for 1 h at room temperature. Subsequent incubations included anti-histone
H2B mAb, followed by peroxidase-coupled goat anti-mouse IgG, each for
1 h at room temperature. The 3,3,5,5-tetramethylbenzidine substrate so-
lution (200 l) was then added to each well. The reaction was stopped after
20 min by adding 100 l of 0.18 M of sulfuric acid, and the absorbance at
450 nm was determined using an ELISA reader. A standard curve was
generated by adding known amounts of histone H2B to the assay.
Results
Purification of salt-resistant antimicrobial proteins from human
placenta
Term placenta was homogenized in an acidic medium and frac-
tionated on a heparin-Sepharose column. Antimicrobial activity
against E. coli of the eluates from the heparin-Sepharose column
was examined in the presence of 150 mM of NaCl. The active
eluate was then subjected to reversed-phase HPLC, and two frac-
tions were found to be responsible for the major salt-resistant an-
timicrobial activity (Fig. 1A). These fractions were further purified
by a second reversed-phase HPLC separation. Each of the fractions
contained a single protein band, as determined by tricine SDS-
PAGE (Fig. 1B). The first protein eluted from the reversed-phase
HPLC column was designated as peak 1 (m.w. of 13,776.2 by
MALDI-MS), and the second one was designated as peak 2 (m.w.
of 13,998.5 by MALDI-MS). The two antimicrobial protein
preparations, which were at 95% purity as determined by re-
versed-phase HPLC, tricine SDS-PAGE, and MALDI-MS, were
subjected to N-terminal sequence analysis (Fig. 1C). Peak 1 was
sequenced up to 20-aa residues, and the sequence was PEPAK-
SAPAPKKGSKKAVTK. This sequence was found to be identical
to the N-terminal sequence of human histone H2B (31). N-terminal
sequencing of peak 2 gave us a very low yield, suggesting that it
was N-terminally blocked. Thus, after an N-terminal deblocking
step (32), peak 2 was sequenced up to 19 residues (SGRGKQG
GKARAKAKTRSS), and the sequence was identical to the N-
terminal sequence of human histone H2A (33). In addition, peak 1
and peak 2 comigrated with calf thymus histone H2B and H2A,
respectively, on a tricine SDS-PAGE (data not shown). On the
basis of the above results, we concluded that histones H2B (peak
1) and H2A (peak 2) are responsible for the major salt-resistant
antimicrobial activity in the human placenta. This conclusion was
further supported by immunoblot analyses, showing that peak 1
reacted strongly with the anti-histone H2B mAb and peak 2 re-
acted strongly with the anti-histone H2A mAb (data not shown).
Antimicrobial assays
The two isolated proteins were then tested for salt-resistant anti-
microbial activity against E. coli. As shown in Table I, the MICs
of purified histones H2A and H2B were determined in the presence
of NaCl, and magainin 2 was included as a control for the com-
parison of salt-dependent antimicrobial activity. There was no sig-
nificant increase in the MICs of histones H2A and H2B in the
presence of up to 300 mM of NaCl, whereas magainin 2 showed
a 10-fold increase in MIC under identical conditions.
LPS-binding and neutralization assays
The purified histones H2A and H2B from the human placenta were
subjected to an LPS-binding assay, which showed that histone
H2B bound to LPS five to six times stronger than did histone H2A
(data not shown). This difference in the binding strength appears to
result from different binding specificity of anti-histone H2A and
anti-histone H2B mAbs (34) in the solid phase binding assay con-
dition (see Materials and Methods). Therefore, the specificity of
binding of histone H2B to the endotoxin LPS was examined. The
LPS of Gram-negative bacteria is composed of three parts: the
lipid A, a relatively conserved core oligosaccharide, and a terminal
polysaccharide of variable length and composition that comprises
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the O-specific Ag domain (35). To determine which part of the
LPS is recognized by the purified histone H2B, inhibition assays
were performed using LPS molecules with various polysaccharide
chain lengths, ranging from lipid A alone (the smallest size), to
Rd2-LPS, Rc-LPS, and Ra-LPS, which consist of the lipid A moi-
ety and variable parts of the core region (Rd2-LPS  Rc-LPS 
Ra-LPS), to 0111:B4 LPS, which has the complete lipid A, core,
and O-Ag domains. As shown in Fig. 2A, the binding of histone
H2B to LPS was inhibited progressively as the length of the core
region of LPS decreased. The Ra-LPS, which lacks the O-Ag do-
mains, bound more tightly than did 0111:B4 LPS. This finding
indicates that the presence of the O-Ag domains either did not
affect or was somewhat inhibitory to LPS binding. Lipid A showed
an affinity to histone H2B similar to that of Rd2-LPS. These results
indicate that both the core region and the lipid A moiety of LPS are
responsible for the LPS-binding activity of histone H2B.
To investigate the endotoxin-neutralizing activity of purified
histones H2A and H2B, we compared their abilities to inhibit LPS-
induced LAL coagulation and block LPS-induced TNF- produc-
tion by the RAW264.7 macrophage cell line. Inhibition of LPS-
induced LAL coagulation by histones H2A and H2B is presented
in Fig. 2B. The effects of PMB and PMBN on LPS-induced LAL
coagulation are shown for comparison. We also tested the effects
of other histones (data not shown). Histones H2A and H2B were
more potent than the other histones tested (H1, H3, and H4) and
PMB, on a molecular basis, in this endotoxin-neutralizing assay.
The results of the TNF- production assays are shown in Fig. 2C.
RAW264.7 cells secrete TNF- upon exposure to endotoxin (36).
FIGURE 1. Purification of salt-resistant antimicrobial proteins. A, Re-
versed-phase HPLC chromatogram of the active fraction from a heparin-
Sepharose column. The fraction with antimicrobial activity that was eluted
with 1 M of NaCl from a heparin-Sepharose column was subjected to
chromatography on a C4 reversed-phase HPLC column and fractionated
with a 0–100% gradient of acetonitrile in 0.13% HFBA. Two active peaks,
which are indicated by the arrows, were further separated by reversed-
phase HPLC on the same column with slower gradient using 0.1% TFA as
the ion-pairing agent. B, Tricine SDS-PAGE analysis of purified antimi-
crobial proteins. The purified proteins, named peak 1 and peak 2, were
subjected to 10% tricine SDS-PAGE. Lane 1, m.w. marker; lane 2, crude
extract from human placenta; lane 3, heparin-affinity chromatography frac-
tion eluted with 1 M of NaCl; lanes 4 and 5, peak 1 and peak 2 purified by
reversed-phase HPLC. C, Alignment of the N-terminal amino acid se-
quences of the purified antimicrobial proteins with those of H2A and H2B.
The amino acid residues are shown using the single-letter codes. The amino
acid sequences of peak 1 and peak 2 are aligned with those of human
histone H2B and H2A, respectively.
FIGURE 2. Characteristics of LPS binding and neutralization by his-
tone proteins. A, Effect of various species of LPS on the binding of histone
H2B to control LPS. The plate was coated with E. coli 0111:B4 LPS, and
histone H2B (1 g/ml) was added to the wells, along with the various LPS
species. Binding is expressed as the percentage of histone H2B bound to
the various types of LPS. A standard curve was generated for comparison
by adding known amounts of histone H2B to the assay. B, Dose-dependent
inhibition of endotoxin-induced LAL coagulation by histone proteins. LAL
was incubated with 1 EU/ml E. coli 0111:B4 LPS in the presence or ab-
sence of the indicated amounts of histone proteins. A standard curve was
generated by adding known amounts of endotoxin to the assay. C, Dose-
dependent suppression by histone proteins of LPS-induced TNF- secre-
tion in RAW264.7 cells. RAW264.7 cells were incubated with 10 ng/ml E.
coli 0111:B4 LPS in the presence or absence of the indicated amounts of
histone proteins for 6 h. TNF- in the supernatant was measured by
ELISA. The LPS-stimulated value was used as 100%, and the data are
represented as the percentage of inhibition of LPS-stimulated TNF- pro-
duction by the histone proteins. Each value represents the mean and SEM
for the averages of duplicate samples from three independent experiments.
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A linear relationship between TNF- secretion and endotoxin con-
centration was observed at LPS concentrations below 20 ng/ml,
and a concentration of 10 ng/ml was selected for the following
experiment. Mixing LPS with increasing concentrations of his-
tones resulted in a dose-dependent suppression of LPS-induced
TNF- secretion (Fig. 2C). Similar to the results of the LAL assay,
histones H2A and H2B exhibited a similar or slightly higher po-
tency than did PMB in suppressing TNF- secretion induced by
LPS. Each reaction was performed in duplicate, and the reported
values, expressed as percentage of inhibition of endotoxin activity,
were calculated from the results of three assays executed on
separate days.
As a control for any possible effects of trace amounts of impu-
rities (e.g., organic compounds) on the antimicrobial and endotox-
in-neutralizing activities of the purified histones H2A and H2B, we
performed these assays (antimicrobial assay, LAL assay, and
TNF- production) with an irrelevant protein (m.w. of 8000),
purified by the same procedure, showing no antimicrobial activity.
No effect was observed with an irrelevant protein under our ex-
perimental conditions. Furthermore, antimicrobial and endotoxin-
neutralizing activities of calf thymus histones H2A and H2B were
identical with those of the purified histones H2A and H2B. The
effect of the purified proteins (an irrelevant protein, histones H2A
and H2B) on the viability of RAW264.7 macrophages was also
examined. The viability was not changed upon addition of the
purified proteins (up to 25 g/ml of final concentration) and at the
end of the incubation (data not shown). Taken together, our results
indicate that the effects of histones H2A and H2B on the antimi-
crobial and endotoxin-neutralizing activities are specific for the
microbes and LPS-induced response.
Expression of histone proteins in human amnion epithelial cells
and trophoblasts
To investigate the expression of histone proteins in human pla-
centa in vivo, Formalin-fixed tissues were subjected to immuno-
histochemical analysis using anti-histone H2A and anti-histone
H2B mAbs, and the results are shown for representative placental
tissue sections (Fig. 3). The histones H2A and H2B proteins in
second trimester placenta (20 wk of gestation) were prominent in
the cytoplasm of syncytiotrophoblasts and amnion epithelial cells,
where they were localized mainly on the surface epithelium. Cho-
rionic cytotrophoblasts contained little or no H2A and H2B. Con-
trol isotype-matched IgG did not bind to any cells in placenta (data
not shown). In term placenta, immunoreactivities with anti-histone
H2A and anti-histone H2B mAbs were less intense in both syn-
cytiotrophoblasts and amnion epithelial cells (data not shown).
These results confirmed that expression of histones H2A and H2B
occurs in the placenta during pregnancy, and indicate that the two
proteins are expressed specifically at the maternal-fetal interface,
with synthesis prominent in syncytiotrophoblasts and amnion ep-
ithelial cells.
Localization of histones H2A and H2B at the surface of amnion-
derived WISH cells
The immunohistochemical analyses suggest that histones H2A and
H2B are mainly localized at the surface epithelium of fetal mem-
branes. To confirm this localization, we did immunocytochemistry
using confocal immunofluorescence microscopy. Fig. 4 shows that
both H2A and H2B are present at the surface epithelium of am-
nion-derived WISH cells. The mAbs stained nuclei of permeabil-
ized WISH cells (Fig. 4, A, C, G, and I), as was expected, because
histones H2A and H2B are nuclear Ags. In addition, immunore-
action of anti-histone H2A (Fig. 4, A and C) and anti-histone H2B
mAbs (Fig. 4, G and I) with the cell surface was also observed. To
further verify the localization of histones H2A and H2B at the cell
surface, the same experiment was performed with nonpermeabi-
lized cells. Cells were fixed and immunolabeled without further
Triton X-100 treatment. The anti-histone H2A (Fig. 4, D and F)
and anti-histone H2B mAbs (Fig. 4, J and L) showed strong stain-
ing on the cell surface, clearly indicating the presence of cell sur-
face-associated histones H2A and H2B in nonpermeabilized cells.
Similar immunostaining results were also obtained in the LPS-
treated WISH cells (data not shown). This observation supports the
concept that histones H2A and H2B are synthesized and localized
at the surface of amnion cells and released into the extracellular
environment.
Extracellular release of histone H2B by amnion cells
We tested H2B production by amnion epithelial WISH cells. We
obtained supernatants from cultured WISH cells treated with LPS
and measured the accumulation of histone H2B in the culture su-
pernatant over time with a sensitive ELISA. Fig. 5 shows that
within 3 h of culture, there is a rapid appearance of histone H2B
in the culture supernatants. Maximum histone H2B production was
observed after 24 h in culture in all LPS-treated culture samples.
After 24 h, histone H2B concentrations in the supernatants ranged
from 10 to 15 ng/ml, as determined by comparison with known
amounts of a histone H2B standard. The levels of histone H2B
production were not variable in response to LPS treatment, sug-
gesting a constitutive production and secretion of histone H2B by
WISH cells. We next studied whether antimicrobial concentrations
of histones H2A and H2B could be generated under biologically
relevant conditions. We measured the levels of histone H2B in
human amniotic fluids by a specific ELISA. The concentrations of
histone H2B from amniotic fluid were found to be 250 67 ng/ml.
The data are presented as the mean  SEM for three separate
experiments from 20 different normal individuals.
Histones H2A and H2B contribute to bactericidal activity of
amniotic fluid
Amniotic fluid, like other body fluids, is known to possess inherent
bactericidal properties (37, 38). When amniotic fluid (10 l) was
incubated with 1 103 CFU of E. coli, up to 100% of the exposed
FIGURE 3. Immunohistochemical localization of histones H2A and
H2B in human placenta. Sections of placental tissues were immunostained
for histone H2A (A and C) and histone H2B (B and D). Histones H2A and
H2B were localized in the cytoplasm of syncytiotrophoblasts (arrows; A
and B) and amnion epithelial cells (arrowheads; C and D), where they were
primarily associated with the surface epithelium. All sections are shown at
a magnification of 400. Similar results were noted in all placental tissues
of varying gestational ages.
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microorganisms were killed (Fig. 6A), and a similar result was
obtained when amniotic fluid was incubated with group B Strep-
tococcus (Fig. 6B). To address the contribution of histones H2A
and H2B to the bactericidal activity of amniotic fluid, we used
specific Abs to block the antimicrobial activity of histones H2A
and H2B in amniotic fluid. The mAbs to histones H2A and H2B
neutralized up to 65% and 58% of the bactericidal activity of am-
niotic fluid incubated with E. coli or group B Streptococcus, re-
spectively (Fig. 6). The bactericidal activity of amniotic fluid was
inhibited dose dependently by the mAbs to H2A and H2B. Con-
sistent with these findings, the bactericidal activity of amniotic
fluid was almost unaffected by control isotype-matched IgG. From
these experimental results, we could infer that amniotic fluid main-
tains amniotic sterility during bacterial infection, and histones
H2A and H2B contribute in part to the bactericidal activity of
amniotic fluid.
Discussion
In this study, we have demonstrated that the salt-resistant antimi-
crobial and endotoxin-neutralizing proteins of the human placenta
are histones H2A and H2B. These proteins may play an important
role in protection of the fetus from invading microorganisms.
Histones H2A and H2B were bactericidal for our E. coli test strain
even in the presence of high salt (up to 300 mM of NaCl). NaCl is
the most predominant salt in vivo, and the ability to resist salt is
important for host defense proteins to function under physiological
FIGURE 4. Immunocytochemical detection of histones H2A and H2B
at the amnion WISH cell surface. Permeabilized cells (A–C and G–I) or
nonpermeabilized cells (D–F and J–L) were treated with the anti-histone
H2A (A–F) or anti-histone H2B mAbs (G–L), biotinylated secondary Ab,
and streptavidin-FluorGreen conjugate in sequence (green, left panel of
each row). The nuclei were counterstained with DAPI (blue, middle panel
of each row). Merged images were generated by computer-assisted super-
imposing FluorGreen and DAPI images (right panel of each row). The
confocal laser photomicrographs show the distribution of histones H2A
and H2B at the surface epithelium as well as within the nuclei of WISH
cells. The magnification is 400. The data shown are representative of
three independent experiments. WISH cells incubated with the mouse iso-
type-matched IgG, as a negative control, showed no reactivity (data not
shown).
FIGURE 5. Secretion of histone H2B in supernatants from cultured
WISH cells. Amnion-derived WISH cells were cultured at 105 cells/ml for
48 h, and the concentration of histone H2B in the cultured supernatants was
quantitated with a highly specific ELISA. The secretion of histone H2B in
the supernatant reached a maximum at 24 h and did not change in response
to LPS treatment. The observed H2B concentrations were expressed as the
mean  SEM for duplicate samples from three independent experiments.
FIGURE 6. Contribution of histones H2A and H2B to bactericidal ac-
tivity of amniotic fluid. Amniotic fluid (10 l) was combined in triplicate
with mAbs to histones H2A and H2B or with control isotype-matched IgG
(10–200 g/ml) for 30 min and analyzed for bactericidal activity against
1  103 CFU of E. coli (A) or group B Streptococcus (B). After 30 min at
37°C, surviving CFU were quantified by growth on semisolid media at
37°C overnight. The bactericidal activity of amniotic fluid was inhibited
dose dependently by the mAbs to H2A and H2B. Bactericidal activity is
expressed as percentage of bacteria killed relative to bacteria unexposed to
amniotic fluid  SEM. F, Amniotic fluid with mAbs to H2A and H2B; E,
amniotic fluid with control isotype-matched IgG.
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conditions. In the case of cystic fibrosis, it has been suggested that
the susceptibility of epithelial antimicrobial proteins (presumably
-defensins) to inhibition by salt explains the persistence of
chronic Pseudomonas aeruginosa infections in the lungs of pa-
tients with this disease (39). Mounting evidence indicates that an-
timicrobial proteins play key roles in the innate immune defenses
of vertebrates. However, their activity is often abrogated under
physiological conditions (100–150 mM of NaCl) (20, 40). A so-
dium concentration of 135 mM has been reported to be present in
the amniotic fluid of human placenta (41). Therefore, the findings
of this study support the hypothesis that retention of antimicrobial
activity in physiological salt concentrations is important for host
defense in the placental physiological environment.
In addition to their antimicrobial activity, naturally occurring
cationic proteins have been shown to bind LPS and block its ability
to stimulate the production of TNF-, IL-6, and other inflamma-
tory mediators (42–44). Systemic disease associated with the pres-
ence of pathogenic microorganisms or their toxins in the blood
often involves Gram-negative bacteria and the release of a bacte-
rial outer membrane component, an endotoxin (45). The toxicity of
the endotoxin, which is also known as LPS, is contained within the
lipid A domain (46). The physiological mechanism whereby en-
dotoxin exerts its effect on humans involves the release of cyto-
kines, most significantly TNF- (47). In the human placenta, LPS
is a potent biological product capable of inducing PG release from
several cell types and, therefore, may be involved in the onset of
human parturition when an intra-amniotic infection exists (48–50).
Given that a heparin-binding lectin from human placenta was hy-
pothesized to be histone H2B (51) and that a neuronal LPS-binding
protein was identified as histone H1 (52), we were prompted to
investigate the LPS binding and neutralization abilities of histones
H2A and H2B. To date, the majority of studies on host defense
involving histone proteins have been focused on broad-spectrum
antimicrobial activities (24, 53, 54). The interaction of histone pro-
teins with LPS and the influence of the O-Ag, core, or lipid A
domains of LPS on LPS binding to histones had heretofore not
been evaluated. To characterize the binding of histone proteins to
LPS, we used a solid phase binding assay with microtiter plates
whose binding surfaces were coated with bacterial LPS. Using this
assay, we found that histone H2B binds avidly to many different
LPS isolates from smooth and rough strains of E. coli, with a high
degree of specificity for the core and lipid A domains of
bacterial LPS.
However, the binding ability alone appears to be a deceptive
indicator of endotoxin-neutralizing activity, as molecules with
nearly the same binding propensities could either opsonize or se-
quester the endotoxin (55, 56). This is clearly evident in the com-
parison of the antiendotoxic activity of PMB and its derivative
PMBN (57). The only difference between PMB and PMBN is the
absence of the 6-heptanoyl/octanoyl diaminobutyryl group at
the amino terminus of the latter. This difference is responsible for
the poor antiendotoxic activity of PMBN (58), despite apparent
similarities in LPS binding ability (59). Therefore, we examined
directly the antiendotoxic activity of histones H2A and H2B. Hi-
stones H2A and H2B showed dose-dependent inhibition of the
endotoxin activity of LPS comparable with that of PMB. Histones
H2A and H2B most likely exert their antiendotoxin actions by
binding to the lipid A moiety and, consequently, blocking the bi-
ological effects of endotoxin. It is known that the lipid A portion
of endotoxin is responsible for the activation of LAL (60) and
stimulation of TNF- secretion (46). This notion is further sup-
ported by our observation that histone H2B bound directly to lipid
A. Given the fact that most known antiendotoxin proteins are cat-
ionic in nature and that both the lipid A and oligosaccharide core
portions of LPS are anionic, one may postulate that electrostatic
forces contribute to the binding of LPS to the neutralizing cationic
histone proteins. Because the E. coli lipid A domain investigated in
this study is similar to that of many Gram-negative pathogens, it is
probable that histones H2A and H2B would also bind to and neu-
tralize the lipid A region of many of the clinical isolates of Gram-
negative pathogens taken from human placental tissues. By anal-
ogy with LPS-binding antimicrobial peptides (61, 62), histone
H2A or H2B binding to or complex formation with free LPS re-
leased from dividing or dying Gram-negative bacteria could also
block the LPS-induced synthesis and secretion of cytokines such
as TNF- that frequently lead to fatal septic shock.
Because the histone H2A and H2B proteins are normally ex-
pressed predominantly in eukaryotic nuclei, we performed further
studies to localize the presence of histones H2A and H2B in pla-
cental tissues. Immunohistochemistry on tissue sections showed
that in addition to being present in nuclei, histones H2A and H2B
were also present in the cytoplasm of syncytiotrophoblasts and
amnion epithelial cells. Of note is the finding that histones H2A
and H2B were localized on the extracellular surface, forming
band-like barriers on the amnion and trophoblast layers. The tro-
phoblast layer, which forms the outer layer of chorion, comprises
both cytotrophoblasts and syncytiotrophoblasts, and the syncy-
tiotrophoblasts represent differentiated, fused cytotrophoblasts
(63). Syncytiotrophoblasts, which are continuously bathed in ma-
ternal blood, were one of the major cell types that contained im-
munoreactive histones H2A and H2B. Thus, histones H2A and
H2B are likely to play important roles in maintaining the barrier
function of the immune-privileged placenta. The coating of his-
tones H2A and H2B on the syncytiotrophoblast layer may serve to
limit the infection and colonization of microbial pathogens via the
hematogenous route. The chorion and amnion epithelial cells form
the outer and inner layers of the chorioamnion, respectively. These
layers are separated by a collagen-rich stroma and by basement
membranes. The chorion and amnion cells form two important
cellular barriers protecting the fetus from bacterial infection. Re-
cent studies suggest that the amnion epithelial cell monolayer may
provide an effective barrier against entry of microbial pathogens to
the nutrient-rich amniotic fluid (64), and may partially explain why
the rate of amniotic fluid infections associated with chorioamnio-
nitis is not higher (65, 66). Moreover, bacterial LPS fails to cross
the chorioamniotic membranes, possibly due to the presence of
LPS-binding proteins (67). We speculate, therefore, that the failure
of both microbial pathogens and bacterial LPS to cross the pla-
cental membranes may be attributed in part to the antimicrobial
and endotoxin-neutralizing potential of histone H2A and H2B pro-
teins coating the epithelial surface of the placenta.
Recently, the presence of histones in both the cytoplasm and
nucleus has been reported (24, 53, 54, 68, 69), and the secretion of
histone proteins into the extracellular milieu was also observed
(24, 70–72). It is becoming clear that histone proteins are present
in both the cytoplasm and the nucleus of rapidly regenerating or
transcriptionally active cells such as placental, gastrointestinal (24,
54), and skin (73, 74) epithelial cells. Indeed, we detected nuclear
staining of some syncytiotrophoblasts and amnion epithelial cells
with anti-phospho-histone H3 Ab, a mitosis marker (data not
shown). Histone H3 phosphorylation at Ser10 correlates temporally
with mitosis in mammalian cells (75, 76).
It appears that the expression of histones H2A and H2B is not
up-regulated during infections in human placenta. In fact, our find-
ings indicate that histones H2A and H2B are constitutively pro-
duced in cultured WISH cells. The constitutive presence of his-
tones H2A and H2B at fetal membrane is most likely relevant for
immediate defense response, since de novo synthesis of histones
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H2A and H2B is not needed when bacterial intruders enter the
placenta. The antimicrobial and endotoxin-neutralizing potentials
of histones H2A and H2B may contribute to the establishment of
a local defense barrier at fetal membrane against microbial infec-
tion and LPS-induced inflammation, causing preterm birth and
neonatal fetal demise. It has been reported that improved host de-
fense is likely to have favored the constitutive expression of anti-
microbial proteins in tissues that are continually exposed to infec-
tions or that are especially important, e.g., those of the
reproductive tract (28, 77, 78). Goldman et al. (39) reported that
antimicrobial activity in airway surface fluid of human bronchial
xenografts is almost diminished by antisense inhibition of consti-
tutively expressed human -defensin-1. The mean value for the
concentration of histone H2B in amniotic fluid is 250 ng/ml.
Considering that the amount of histone H2A is similar to that of
histone H2B in the placental tissues (Fig. 1B), the total concen-
tration of histones H2A and H2B in amniotic fluid may be 500
ng/ml, which is much lower than MIC value of 10 g/ml. How-
ever, the MIC value under our experiments was determined with
an inoculum size of 5  104 CFU of E. coli. Studies on measuring
the antimicrobial potency of histones H2A and H2B by CFU
counting assay showed that the total concentration (500 ng/ml) of
histones H2A and H2B was enough to inhibit the growth of an
inoculum size of 5–10  102 CFU of E. coli (data not shown).
From this observation, we speculate that the concentration of
histones H2A and H2B in amniotic fluid may be sufficient to be
microbicidal for a small number of microorganisms that breached
constitutive defenses at amniotic membranes and gained access to
the intra-amniotic cavity. The histones H2A and H2B may be con-
centrated at the sites of their secretion onto the negatively charged
epithelial surface, and the actual histone concentrations at the site
of placental infection might be substantially higher. Further studies
are necessary to evaluate the functional contributions of histones
H2A and H2B to innate immune defenses in human placenta
in vivo.
In conclusion, the antimicrobial and endotoxin-neutralizing ac-
tivities of histones H2A and H2B and their detection in syncy-
tiotrophoblasts and amnion cells suggest the existence of a novel
mechanism by which the fetus and placenta are protected against
microbial infection. Therefore, histones H2A and H2B may form
an important and previously unrecognized defense for the im-
mune-privileged human placenta.
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